GlaxoSmithKline 'plans to axe thousands of jobs'

Drugs giant GlaxoSmithKline is expected to announce plans to axe up to 4,000 jobs this week as part of its ongoing restructuring, it was reported today.

It is thought the majority of the cuts will be made to its European and US workforce, as the group shifts its focus to emerging markets, according to the Sunday Times newspaper.